Advisor Group Holdings, Inc. Ice Cure Medical Ltd. Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.16 - $1.48 $9,280 - $11,840	8,000 Added 110.34%	15,250 $18,000
Q4 2023 Feb 12, 2024	BUY	$0.72 - $1.36 $5,220 - $9,860	7,250 New	7,250 $7,000
Q1 2023 May 12, 2023	BUY	$1.05 - $1.49 $525 - $745	500 Added 9.67%	5,670 $6,000
Q3 2022 Nov 14, 2022	BUY	$1.12 - $2.03 $2,800 - $5,074	2,500 Added 93.63%	5,170 $7,000
Q2 2022 Aug 10, 2022	BUY	$1.71 - $2.47 $1,145 - $1,654	670 Added 33.5%	2,670 $4,000
Q1 2022 May 04, 2022	SELL	$2.01 - $3.31 $2,512 - $4,137	-1,250 Reduced 38.46%	2,000 $5,000
Q3 2021 Nov 05, 2021	BUY	$8.61 - $11.33 $27,982 - $36,822	3,250 New	3,250 $29,000

364K

Ticker ICCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 36,835,600
Market Cap $31.3M
Description
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.